Use of 5α-reductase inhibitors for lower urinary tract symptoms and risk of prostate cancer in Swedish men: nationwide, population based case-control study.
BMJ. 2013 Jun 18;346:f3406. doi: 10.1136/bmj.f3406.
BMJ. 2013.
PMID: 23778271
Free PMC article.